IL5 and Increased total eosinophil count: Priming in vivo for an increased ex vivo response to the eosinophil-selective growth and differentiation factor, interleukin (IL)-5, is an important component of the hematological response to allergen challenge [9], which parallels in vivo eosinophilia but is independently regulated [29].